Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Author's Avatar
Aug 15, 2022

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced second quarter 2022 results and provided a business update.